Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized tacrolimus dosing with once-daily formulation in pediatric kidney transplant recipients
2024-511585-36-00Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Jun 2024
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tacrolimus in Kidney allograft status (RTx) (2 arms), sponsored by Erasmus MC. Started Jun 2024; status: completed.
02
Drugs
tacrolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2024-511585-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511585-36-00.